Abstract Background Cancer screening tests are considered pivotal for early diagnosis and survival. However. the efficacy of these tests for improving survival has recently been questioned. This study aims to test if cancer screening could be improved by biomarkers in peripheral blood based on multi-omics data. https://foldlyers.shop/product-category/6-speakers/